Anchiano starts Codex study for bladder cancer drug
Anchiano Therapeutics has commenced the Codex, a Phase ll trial examining the efficacy and safety...
Anchiano Therapeutics has commenced the Codex, a Phase ll trial examining the efficacy and safety...